Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Long-Term Use of Antithyroid Drugs
source: Graves’ Disease & Thyroid Foundation (GDATF)
Antithyroid medications (ATDs) have been prescribed for decades as a treatment option for hyperthyroidism in Graves’ disease patients. The U.S. Food and Drug Administration approved propylthiouracil in 1947 and methimazole (brand name Tapazole) in 1950.
In the past, endocrinologists typically prescribed ATDs for a limited period of time. Some doctors used 12-18 months as a benchmark, while others would keep patients on the medication for up to two years. Once the clock ran out, doctors stopped the medication and checked the patient’s thyroid function. If levels were in the normal range, the treatment was declared a success. If thyroid levels were still not well controlled (or if the patient became hyperthyroid again after stopping the medication) doctors would recommend radioactive iodine or surgery, which are definitive therapies that result in life-long hypothyroidism.
However, a paradigm shift in recent years – ushered in by new research as well as patient and physician preference – has brought changes to how these medications are used, with more patients remaining on antithyroid medications well past the two-year mark.
Combination Treatment With T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?Context: Levothyroxine therapy is the t...
Symptoms Strongly Drive the Consideration of Alternative Thyroid Hormone-Replacement Options in Patients With Hypoth...The standard treatment for hypothyroidis...
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thy...Background: Thyrotoxicosis has multip...
Radioactive Iodine Can Be First-Line for Hyperthyroidism, Says UKNew UK guidelines for the treatment of h...
University of Utah Health – Thyroid & Parathyroid ClinicThe Thyroid & Parathyroid Clinic at ...
Drug-Like Compound Stops Thyroid Overstimulation in Early NIH StudiesResearchers at the National Institutes o...
Increased Cancer Incidence After Radioiodine Treatment for HyperthyroidismBackground: Concerns remain about risk ...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.